title: Treatment of anaemia of progressive renal failure with recombinant human erythropoietin. A preliminary report.
abstract: We report response in anaemia and wellbeing of a lady with chronic renal disease treated with recombinant human erythropoietin 5000 units thrice weekly. Without any blood transfusions, the patient's haematocrit improved (20% to 35%) and a subjective improvement in wellbeing and appetite was noted. This drug seems to be a breakthrough in the management of anaemia of chronic renal diseases, including end stage renal disease, avoiding the risks of repeated blood transfusions.
authors.affiliation: Division of Haematology, Calicut Medical College and Hospital, Kerala.
authors.forename: K A
authors.initials: KA
authors.lastname: Salim
authors.forename: S
authors.initials: S
authors.lastname: Salim
authors.forename: T
authors.initials: T
authors.lastname: Mathew
mesh_terms: D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D006400:Hematocrit; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications*; D008875:Middle Aged; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin